1 Unexpectedly low plasma concentrations of mexiletine were observed in three patients treated with mexiletine and concurrently taking phenytoin. 2 Six healthy volunteers were given a single oral dose of mexiletine (400 mg), before and after 1 week of phenytoin administration (300 mg/day). 3 The mean +/‐ s.d. area under the plasma mexiletine concentration‐time curve decreased from 17.67 +/‐ 6.21 to 8.01 +/‐ 3.64 micrograms ml‐1 h (P less than 0.003). 4 The mean +/‐ s.d. half‐life of elimination of mexiletine decreased from 17.2 +/‐ 5.26 to 8.4 +/‐ 4.17 h (P less than 0.02) 5 The suggested mechanism of the interaction is hepatic mixed‐function oxidase enzyme induction by phenytoin. 6 The interaction is likely to be clinically significant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.